Link between antihyperglycemic drugs and cancer is unproved, US endocrinologists sayBMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f5285 (Published 27 August 2013) Cite this as: BMJ 2013;347:f5285
- Michael McCarthy
Current evidence linking the use of antihyperglycemic drugs with a raised risk of developing cancer is “limited and conflicting,” say the American Association of Clinical Oncologists and the American College of Endocrinology. Their consensus statement says that clinicians “can continue to confidently prescribe all FDA-approved antihyperglycemic medications for the management of hyperglycemia.”1
The statement was developed in response to growing concerns about the possible association between obesity, diabetes, and, in particular, the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial